Influenza vaccines for preventing cardiovascular disease-Reference-Cited by-同舟云学术

Influenza vaccines for preventing cardiovascular disease

Published:2015-05-05 Issue:5 Volume:2015 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Clar Christine¹,Oseni Zainab²,Flowers Nadine²,Keshtkar-Jahromi Maryam³,Rees Karen²

Affiliation:

1. Freelance; Hasenheide 67 Berlin Germany 10967

2. Warwick Medical School, University of Warwick; Division of Health Sciences; Coventry Warwickshire UK

3. Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center; Division of Infectious Diseases; Mason F.Lord Building, Center Tower, Suite 381 5200 Eastern Avenue Baltimore MD USA 21224

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005050.pub3/fullpdf

Reference80 articles.

1. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older;Villiers;Vaccine,2009

2. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study;Ciszewski;European Heart Journal,2008

3. The protective effect of influenza vaccination on the clinical course of coronary disease in patients with acute coronary syndromes treated by primary PCI - A report from FLUCAD study;Ciszewski;Postepy w Kardiologii Interwencyjnej,2010

4. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study;Gurfinkel;European Heart Journal,2004

5. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry;Gurfinkel;Texas Heart Institutional Journal,2004

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events affecting recovery from seasonal influenza vaccination in the hypertensive population: A population-based pharmacovigilance analysis;2024-09-04

2. Mathematical modeling for estimating influenza vaccine efficacy: A case study of the Valencian Community, Spain.;Infectious Disease Modelling;2024-09

3. Laboratory-confirmed respiratory viral infection triggers for acute myocardial infarction and stroke: Systematic review protocol;PLOS ONE;2024-07-10

4. Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis;BMJ Open;2024-07

5. Influenza Infection and Acute Myocardial Infarction;NEJM Evidence;2024-06-25